• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

超越人类增强——认真对待发展中国家的视角

'Beyond' Human Enhancement - Taking the Developing Country's Perspective Seriously.

作者信息

Sachdev Vorathep

机构信息

The University of Edinburgh, Edinburgh, UK.

出版信息

Asian Bioeth Rev. 2021 Oct 8;14(2):169-182. doi: 10.1007/s41649-021-00193-z. eCollection 2022 Apr.

DOI:10.1007/s41649-021-00193-z
PMID:35462965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8986940/
Abstract

Bioethicists and philosophers dominate the on-going debate on human enhancement. They have debated the definition of human enhancement as well as the potential impacts of human enhancement technologies (such as pharmaceutical enhancements or pre-natal selection). These discussions have percolated, through bioethics bodies and bioethics recommendations, policy makers and have eventually been translated into policy. While some suggestions have been based largely in Western liberal democracies, others have deliberated the geopolitical consequences of human enhancement technologies. This paper argues that the present debate currently lacks perspectives from developing countries. It begins by introducing the current debate on human enhancement and recognizes Allen Buchanan's well-raised concerns on how these technologies may potentially cause new injustices for low- and middle-income countries ('developing countries'). It then provides two arguments calling for further research into human enhancement from the perspective of developing countries. First, this paper will argue that the current frames with which enhancement technologies are viewed are inherently neoliberal and require change. The second argument shows how the potential impacts of human enhancement technologies in developing countries have not been fully realized by analyzing how human enhancement technologies will impact Thailand, a developing country.

摘要

生物伦理学家和哲学家主导着正在进行的关于人类增强的辩论。他们辩论了人类增强的定义以及人类增强技术(如药物增强或产前选择)的潜在影响。这些讨论通过生物伦理机构和生物伦理建议渗透到政策制定者中,并最终转化为政策。虽然一些建议主要基于西方自由民主国家,但其他建议则审议了人类增强技术的地缘政治后果。本文认为,目前的辩论目前缺乏来自发展中国家的观点。文章首先介绍了当前关于人类增强的辩论,并认识到艾伦·布坎南对这些技术可能如何给低收入和中等收入国家(“发展中国家”)带来新的不公正提出的合理担忧。然后提供了两个论点,呼吁从发展中国家的角度对人类增强进行进一步研究。首先,本文将论证,目前看待增强技术的框架本质上是新自由主义的,需要改变。第二个论点通过分析人类增强技术将如何影响发展中国家泰国,展示了人类增强技术在发展中国家的潜在影响尚未得到充分认识。

相似文献

1
'Beyond' Human Enhancement - Taking the Developing Country's Perspective Seriously.超越人类增强——认真对待发展中国家的视角
Asian Bioeth Rev. 2021 Oct 8;14(2):169-182. doi: 10.1007/s41649-021-00193-z. eCollection 2022 Apr.
2
Human enhancement and supra-personal moral status.人类增强与超个人道德地位。
Philos Stud. 2013 Feb;162(3):473-497. doi: 10.1007/s11098-011-9778-2. Epub 2011 Aug 26.
3
Biomedical Enhancement and Social Development: A Conservative Techno-Fix.生物医学增强与社会发展:一种保守的技术解决方案。
Bioethics. 2016 Nov;30(9):733-740. doi: 10.1111/bioe.12277. Epub 2016 Sep 26.
4
Managing the health care market in developing countries: prospects and problems.发展中国家医疗保健市场的管理:前景与问题
Health Policy Plan. 1994 Sep;9(3):237-51. doi: 10.1093/heapol/9.3.237.
5
Genetic enhancement, post-persons and moral status: a reply to Buchanan.遗传增强、后人类与道德地位:对布坎南的回应。
J Med Ethics. 2012 Mar;38(3):135-9. doi: 10.1136/medethics-2011-100126. Epub 2011 Nov 10.
6
The Social and Ethical Acceptability of NBICs for Purposes of Human Enhancement: Why Does the Debate Remain Mired in Impasse?用于人类增强目的的纳米-生物-信息-认知技术的社会与伦理可接受性:为何这场辩论仍陷入僵局?
Nanoethics. 2011 Dec;5(3):295-307. doi: 10.1007/s11569-011-0133-z. Epub 2011 Nov 11.
7
Annual Rates of Decline in Child, Maternal, Tuberculosis, and Noncommunicable Disease Mortality across 109 Low- and Middle-Income Countries from 1990 to 20151990年至2015年期间109个低收入和中等收入国家儿童、孕产妇、结核病及非传染性疾病死亡率的年下降率
8
The silencing of Kierkegaard in Habermas' critique of genetic enhancement.在哈贝马斯对基因增强的批判中,克尔凯郭尔的观点被忽视了。
Med Health Care Philos. 2009 Jun;12(2):147-56. doi: 10.1007/s11019-009-9185-z. Epub 2009 Feb 21.
9
Strengthening cost-effectiveness analysis in Thailand through the establishment of the health intervention and technology assessment program.通过建立卫生干预和技术评估计划加强泰国的成本效益分析。
Pharmacoeconomics. 2009;27(11):931-45. doi: 10.2165/11314710-000000000-00000.
10
Autonomy, natality and freedom: a liberal re-examination of Habermas in the enhancement debate.自主性、出生与自由:在强化辩论中对哈贝马斯的自由主义重新审视。
Bioethics. 2015 Mar;29(3):145-52. doi: 10.1111/bioe.12082. Epub 2014 Feb 19.

本文引用的文献

1
Pharmacological Human Enhancement: An Overview of the Looming Bioethical and Regulatory Challenges.人类药理学增强:迫在眉睫的生物伦理与监管挑战概述
Front Psychiatry. 2020 Feb 17;11:53. doi: 10.3389/fpsyt.2020.00053. eCollection 2020.
2
Everyday Cyborgs: On Integrated Persons and Integrated Goods.日常赛博格:论融合之人与融合之物。
Med Law Rev. 2018 May 1;26(2):276-308. doi: 10.1093/medlaw/fwy003.
3
Ethical Concerns About Human Genetic Enhancement in the Malay Science Fiction Novels.马来科幻小说中人类基因增强的伦理问题
Sci Eng Ethics. 2018 Feb;24(1):109-127. doi: 10.1007/s11948-017-9887-1. Epub 2017 Mar 9.
4
Biomedical Enhancement and Social Development: A Conservative Techno-Fix.生物医学增强与社会发展:一种保守的技术解决方案。
Bioethics. 2016 Nov;30(9):733-740. doi: 10.1111/bioe.12277. Epub 2016 Sep 26.
5
Cognitive Enhancement in Healthy Children Will Not Close the Achievement Gap in Education.
Am J Bioeth. 2016 Jun;16(6):39-41. doi: 10.1080/15265161.2016.1170240.
6
Growth hormone, enhancement and the pharmaceuticalisation of short stature.生长激素、身高增长与身材矮小的药物化
Soc Sci Med. 2015 Apr;131:305-12. doi: 10.1016/j.socscimed.2014.10.015. Epub 2014 Oct 7.
7
International law, public health, and the meanings of pharmaceuticalization.国际法、公共卫生与药物化的意义。
New Genet Soc. 2014 Oct 2;33(4):434-449. doi: 10.1080/14636778.2014.951994. Epub 2014 Sep 18.
8
Medical tourism's impact on health care equity and access in low- and middle-income countries: making the case for regulation.医疗旅游对中低收入国家的医疗保健公平性和可及性的影响:为监管辩护。
J Law Med Ethics. 2013 Spring;41(1):286-300. doi: 10.1111/jlme.12019.
9
Moral enhancement, freedom, and what we (should) value in moral behaviour.道德提升、自由以及我们(应该)在道德行为中所重视的东西。
J Med Ethics. 2014 Jun;40(6):361-8. doi: 10.1136/medethics-2012-101157. Epub 2013 Jan 25.
10
Assisted reproductive technologies in Thailand: 2001-2007 results generated from the ART Registry, Royal Thai College of Obstetricians and Gynaecologists.泰国的辅助生殖技术:2001 - 2007年泰国皇家妇产科学院辅助生殖技术登记处的结果
J Obstet Gynaecol Res. 2011 Mar;37(3):236-44. doi: 10.1111/j.1447-0756.2010.01384.x. Epub 2011 Jan 27.